SequelSEC

iSpecimen Inc. ISPC

Services-Commercial Physical & Biological Research · CIK 0001558569 · Fiscal year ends 1231

Revenue
$466.30K
Fiscal year ended 2026-06-30
Operating income
-$9.42M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$2.45MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.08Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Commercial Physical & Biological Research filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue0.0%0th
Revenue YoY growth-79.2%0th
Net margin-543.7%9th
SBC / revenue1.1%9th
Operating margin-465.4%17th
FCF margin-219.9%25th
Gross margin11.2%25th
Current ratio1.12x57th

iSpecimen Inc. (ISPC) reported revenue of $466.30K and net income of -$11.42M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from iSpecimen Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

iSpecimen Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$466.30K
Cost of revenue$971.13K
Gross profit-$504.83K
Operating income-$9.42M
Net income-$11.42M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$6.66M
General & administrative$2.89M
Selling & marketing$3.78M

Balance

iSpecimen Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$4.41M
Total assets$7.39M
Current assets$4.48M
Total liabilities$5.66M
Current liabilities$5.48M
Total equity incl. NCI$1.74M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$21.26K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$4.67M

Cash flow

iSpecimen Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$7.00M
Capital expendituresUnavailable
Investing cash flow-$1.70M
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensation$4.74K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.20M

Derived

iSpecimen Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin-108.3%
Operating margin-2020.0%
FCF marginUnavailable
SBC / revenue1.0%
Current ratio0.82x
Revenue YoY growth-92.1%
Net margin-2449.0%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ISPC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-18View SEC filing
10-K · Filed 2026-04-01View SEC filing
10-Q · Filed 2025-11-17View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-19View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.